The Fred Hutchinson Cancer Research Center proposes continuation of Cancer Center Support Grant-related activities including 14 shared resources, 12 developed research programs, and three research programs in development within the three scientific divisions of the Center: Basic Sciences, Clinical Research and Public Health Sciences. Support for senior leadership, leaders of established research programs, staff investigators, planning and evaluation, development and interim funds, administration, and clinical trial protocol review is proposed. The Center continues to develop and broaden the applicability of bone marrow transplantation as the core of clinical research activities. In addition, the Center supports a regional oncology group, the Puget Sound Oncology Consortium, which links oncology practitioners and the principal institutions in the region for purposes of clinical cancer research and cancer prevention protocols. The Division of Public Health Sciences has added a new program in Cancer Biology which brings together epidemiology and laboratory science, initially focused on the epidemiology and carcinogenic activity associated with human papillomavirus (HPV) infections. Added laboratory science in molecular genetics, carcinogenesis and nutritional biochemistry is planned, and major efforts in cancer prevention research, epidemiology and biostatistics continue. The Division of Basic Sciences laboratories exploit model systems for studies in cell biology, genetics, molecular biology and immunology, viral oncology and developmental biology related to fundamental processes altered in neoplasia. The interdisciplinary Program in Molecular Medicine has expanded and continues to focus on laboratory approaches to the study of cancer in humans. Space available to the Center will expand to accommodate enhanced laboratory programs in all three scientific divisions and Molecular Medicine. Shared resources include: (1) a group of facilities that support laboratory research and/or are laboratory-based: Animal Health Resources, Biological Production Facility, Cryobiology, Histology, Glassware Facility, and Microchemistry; three resources that support the cell analysis function: Electron Microscopy, Flow Cytometry and Image Analysis; and (3) computing and information resources, two of which provide centerwide support, Information Services and Library Services, and three which are utilized throughout the Center but primarily support one of the scientific divisions: Biocomputing, Clinical Information, and Epidemiology and Biostatistics. The Clinical Trial Protocol Review and Monitoring System is closely associated to Clinical Information and supports protocol-based clinical cancer research of the Puget Sound Oncology Consortium.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA015704-21
Application #
2086365
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1993-01-01
Project End
1997-12-31
Budget Start
1994-01-01
Budget End
1994-12-31
Support Year
21
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Briant, Katherine J; Sanchez, Janeth I; Ibarra, Genoveva et al. (2018) Using a Culturally Tailored Intervention to Increase Colorectal Cancer Knowledge and Screening among Hispanics in a Rural Community. Cancer Epidemiol Biomarkers Prev 27:1283-1288
Xu, Chang; Nikolova, Olga; Basom, Ryan S et al. (2018) Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck Cancer. Clin Cancer Res 24:2828-2843
Miller, Chris P; Tsuchida, Connor; Zheng, Ying et al. (2018) A 3D Human Renal Cell Carcinoma-on-a-Chip for the Study of Tumor Angiogenesis. Neoplasia 20:610-620
Baker, K Scott; Syrjala, Karen L (2018) Long-term complications in adolescent and young adult leukemia survivors. Hematology Am Soc Hematol Educ Program 2018:146-153
Gavvovidis, Ioannis; Leisegang, Matthias; Willimsky, Gerald et al. (2018) Targeting Merkel Cell Carcinoma by Engineered T Cells Specific to T-Antigens of Merkel Cell Polyomavirus. Clin Cancer Res 24:3644-3655
Paulson, K G; Voillet, V; McAfee, M S et al. (2018) Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA. Nat Commun 9:3868
Puronen, Camille E; Cassaday, Ryan D; Stevenson, Philip A et al. (2018) Long-Term Follow-Up of 90Y-Ibritumomab Tiuxetan, Fludarabine, and Total Body Irradiation-Based Nonmyeloablative Allogeneic Transplant Conditioning for Persistent High-Risk B Cell Lymphoma. Biol Blood Marrow Transplant 24:2211-2215
Witzky, Anne; Hummels, Katherine R; Tollerson 2nd, Rodney et al. (2018) EF-P Posttranslational Modification Has Variable Impact on Polyproline Translation in Bacillus subtilis. MBio 9:
Rosenthal, Elisabeth A; Shirts, Brian H; Amendola, Laura M et al. (2018) Rare loss of function variants in candidate genes and risk of colorectal cancer. Hum Genet 137:795-806
Verboon, Jeffrey M; Decker, Jacob R; Nakamura, Mitsutoshi et al. (2018) Correction: Wash exhibits context-dependent phenotypes and, along with the WASH regulatory complex, regulates Drosophila oogenesis (doi:10.1242/211573). J Cell Sci 131:

Showing the most recent 10 out of 1267 publications